Aparna Gunda
Bengaluru, KA, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.
Journal: Cancer medicine
Published: December 12, 2022
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.
Journal: Breast cancer research : BCR
Published: December 01, 2022
A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.
Journal: Breast cancer research and treatment
Published: May 27, 2022
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort.
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort.
Journal: Breast (Edinburgh, Scotland)
Published: September 21, 2021
The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin.
Journal: Breast (Edinburgh, Scotland)
Published: March 16, 2021
Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX.
Journal: Cancer medicine
Published: June 23, 2020
Recurrence patterns-analysis from a South Indian breast cancer patient cohort.
Journal: Indian journal of cancer
Published: May 29, 2020
Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients.
Journal: BMC cancer
Published: October 17, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026